WHO consults on public disclosure of clinical trial results
This article was originally published in SRA
Executive Summary
The World Health Organization has become the latest entity to take forward ongoing efforts for greater transparency around the conduct of clinical trials by launching a 30-day public consultation on this topic1,2. The public consultation exercise ends on 15 November and will culminate in the WHO issuing an official statement on the public disclosure of clinical trial results.
You may also be interested in...
Medical Research Funders To Implement WHO’s Trial Disclosure Standard
The World Health Organization’s 2015 standard that specifies strict timelines for reporting clinical trial results is to be implemented by major medical research funders and NGOs in a year’s time.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EMA Hopes New Requirement Will Make Companies Stick To Their Filing Plans
An additional form that marketing authorization applicants must now complete during the pre-submission stage emphasizes the importance of companies providing accurate information on their intended submission date.